At this year’s LogiPharma 2024 event, we caught up with some of the pharmaceutical supply chain sector’s leading executives to learn more about them, their analysis of the trends shaping the industry, and how their organisations are responding to the challenges ahead.
Here’s Olga Blaut, Country Head of Sales for Pharma & Healthcare at JAS, answering our questions about the event, JAS, and both the ongoing disruption pressuring the industry, and how the pharma supply chain can develop the resilience to survive and thrive in the new normal.
1. Would you be able to give me a brief introduction to your role and the company you work for?
My name is Olga Blaut, and I am the Country Head of Sales for Pharma & Healthcare at JAS. In my role, I navigate the ever-evolving world of pharma logistics with a mission to deliver solutions that are not just effective, but exceptional. I have a noble but challenging task of matching our clients’ needs with JAS’s global expertise to support wellbeing of the patients globally.
On top of that, I am also proud to wear the badge of Pharma & Healthcare Champion at JAS, which is a special certification recognizing our commitment to the highest standards in the industry. So, whether it is about moving medicine across borders or brainstorming the next big logistics innovation, I am your go-to person.
Inside LogiPharma 2024
2. What is the value of events like LogiPharma 2024? How important is this conference in the supply chain pharma calendar?
Events like LogiPharma 2024 are like the Super Bowl of the supply chain pharma calendar—without the commercials, but with all the excitement! These conferences are invaluable because they bring together the brightest minds and biggest innovators in our industry under one roof. It is a prime opportunity to exchange insights, discuss challenges, and uncover the latest trends and technologies shaping the future of pharma logistics.
For me, LogiPharma is not just an event—it is a cornerstone of the year’s strategy.
It is where industry leaders, like us at JAS, can connect with our customers, partners and even competitors to share knowledge and drive the industry forward. The importance of this conference goes beyond networking, it is about staying ahead of the curve, discovering new cold chain solutions, and making sure we’re all aligned in delivering safe, reliable, and innovative supply chain services for healthcare worldwide.
Plus, let us be honest—it is a great place to catch up with old friends and make new ones, all while keeping an eye on the future of pharma logistics!
3. Is there anything that makes this event stand out for you? How is it different from others you’ve attended?
What makes LogiPharma stand out for me is the way it feels like a reunion of the industry’s best and brightest, but always with something new and exciting on the agenda. I had the pleasure of attending LogiPharma in Lyon, which was an incredible experience with its own European flair. But this will be my first LogiPharma event in the USA, and I am thrilled to see how the American side of the industry tackles the same challenges from a different angle.
This year, JAS is taking things up a notch—we have a booth where we are showcasing our latest solutions, and we are also speaking at the event. It is a unique opportunity for us to not only present what we do but also to actively engage with the audience and learn from them too. What really sets this event apart is the level of interaction and collaboration—you are not just attending; you are participating in shaping the future of pharma logistics.
Global supply chain
4. Given the backdrop of the global disruption over the past few years (COVID, wars, inflation etc), how would you sum up where the pharmaceutical supply chain space finds itself today?
Indeed, the pharmaceutical supply chain space today feels like it has been through a series of boot camps—COVID, wars, inflation, you name it. If the past few years have taught us anything, it is that resilience is not just a buzzword; it is a survival skill. We have had to adapt, innovate, and sometimes completely reinvent the way we operate, all while ensuring that critical medications reach patients who need them the most.
Despite the challenges, I would say the industry has emerged stronger, more agile, and laser-focused on building supply chains that are not just efficient, but also robust and adaptable. We are seeing an accelerated push towards digitalization, greater emphasis on data transparency, and more collaborative efforts across the board to tackle disruptions head-on.
JAS presented to the market unique charter solutions between Europe and USA to support pharma flow. JAS has invested in 4 global pharma Centers of Excellence to support local operations of our Customers. We developed device-agnostic visibility platform with full integration capabilities and automated CAPAs process to support our Customers and their patients.
We are in a state of continuous evolution—embracing new technologies, enhancing risk management strategies, and finding new ways to navigate uncertainty. It is not easy, but then again, nothing worth doing ever is. JAS – together with the Industry – is moving from crisis mode to proactive, strategic thinking, and I am excited to see where we go from here.
5. What do you feel are the biggest lessons supply chains have learnt over the past few years and how well equipped is the modern day supply chain now to deal with ‘black swan’ events like the ones we’ve seen recently?
The past few years have been a masterclass in navigating uncertainty, and the biggest lessons supply chains have learned revolve around resilience, adaptability, and the importance of strong relationships. We have seen firsthand how crucial it is to build flexible and transparent supply chains that can quickly pivot in response to unexpected disruptions.
One key lesson is the value of data and technology in enhancing visibility and agility. Modern pharma supply chains are leveraging advanced analytics, digital tools, and real-time tracking to stay ahead of potential temperature excursions, delays and other multiple issues, and make informed decisions for the patients benefits.
Another important takeaway is the power of collaboration, and the strength found in a
committed team. At JAS, we truly believe in our motto “People Make the Difference.” Our values emphasise the importance of a cohesive team—our JAS family—that goes above and beyond to support our clients and adapt to new challenges. It is this collective effort and shared dedication that helps us tackle ‘black swan’ events and emerge stronger.
Today’s supply chains are better equipped to handle these rare and unpredictable events thanks to these lessons. We are more proactive, data-driven, and collaborative than ever before. However, staying prepared for the unexpected remains a continuous journey, and our values and commitment to excellence guide us every step of the way.
Sustainability
6. Sustainability is an important item on most Chief Supply Chain Officers’ agenda. Amid government legislation and changing customer demands, is a sustainable supply chain a non-negotiable in today’s world?
It’s a great question to ask at Logipharma! Did you know that Pharma Industry emits more CO2 than Automotive?
No surprise that it is on the agenda of the Board Meetings of Big Pharma. In today’s world, sustainability is indeed a non-negotiable aspect of supply chain management. It is no longer just about meeting regulatory requirements but also about adapting to evolving customer demands for greener, more responsible practices to save this planet for future generations.
7. In what ways have you incorporated sustainability into operations?
At JAS, we recognize that sustainability is critical for both business success and environmental stewardship.
Amid government legislation and increasing pressure from various stakeholders, we put a lot of efforts to embed sustainability into our core operations. This includes optimising transportation routes to reduce carbon emissions, investing in greener technologies, and working closely with our partners to ensure that our entire supply chain adheres to responsible practices.
Our commitment to sustainability also aligns with our long-term strategy, focusing on innovation and continuous improvement to minimise environmental impact while maximising efficiency. By doing so, we help our customers achieve their own sustainability goals, which has become a key differentiator in the marketplace.
Sustainability is not just about compliance for JAS but also about future-proofing our supply chain against environmental risks, contributing to a more circular economy, and building trust with customers who are increasingly prioritising sustainability in their decision-making processes.
8. People are a company’s greatest asset but can also be a hurdle to overcome when it comes to innovation. How do you manage the people challenge and get them on board with change?
At JAS, we firmly believe that people are indeed our greatest asset— as I mentioned, our company’s motto, “People Make the Difference,” reflects that. However, as with any transformative journey, getting everyone on board with innovation can be challenging. That is why we focus on building a culture of adaptability, open communication, and continuous learning to ensure that our team not only embraces change but thrives in it.
One of the key ways we manage the people challenge is through clear and consistent communication – the size of the company and flat hierarchy allows to execute this without any internal barriers. Thanks to regular CEO, CCO and COO updates, we make sure that our employees understand the why behind the changes we are implementing—whether it’s new technology, processes, or systems. When people see how innovation directly supports the company’s growth, customer satisfaction, and their own professional development, they are far more likely to embrace it.
We also prioritise upskilling and reskilling initiatives. At JAS, we invest in training programs to help our teams develop the technical and soft skills they need to navigate an increasingly digital and data-driven environment. By empowering our employees with the right tools and knowledge, we alleviate fears around innovation and ensure they are confident contributors to the change process.
Ultimately, we see change as an opportunity for growth, and we align our people strategy with our innovation goals. Through leadership support, ongoing communication, and a focus on development, we ensure that our team is not just on board but is leading the charge toward a more innovative future.
9. What about the next generation of talent? What is the key to encouraging more people into a career within the industry?
Encouraging the next generation of talent into the pharmaceutical and healthcare logistics industry is critical for sustaining innovation and ensuring long-term growth. At JAS, we believe the key lies in creating a purpose-driven environment that not only highlights the vital role we play in saving lives but also offers clear pathways for personal and professional development.
First, we emphasise the impact that a career in this industry can have on society. In the Pharma & Healthcare vertical, every day brings the opportunity to contribute to the timely delivery of life-saving medicines, vaccines, and medical devices. When young professionals see the real-world difference they can make, it adds a deep sense of purpose to their careers, making this sector highly appealing. This is the Industry where “People Make the Difference”.
Secondly, we invest in mentorship and development programs that help new talent grow within the industry. Through internships, apprenticeships, and mentorship initiatives, we provide young professionals with hands-on experience and guidance from industry veterans. This not only helps them develop the technical and operational skills they need but also fosters a strong connection to the industry early on.
Finally, we actively promote diversity and inclusion, ensuring that people from all backgrounds feel welcome and valued. A diverse workforce brings fresh perspectives, and that’s crucial for fostering innovation and encouraging creative problem-solving, which appeals to the next generation of professionals who value inclusion in the workplace.
Looking to the Future
10. How can the pharmaceutical supply chain industry take that next step and what strategies can be implemented to push the industry forward even further?
Taking the next step in the pharmaceutical supply chain industry involves a combination of embracing innovation, enhancing collaboration, and prioritising sustainability.
Embracing AI, machine learning, and blockchain today revolutionise our operations. Imagine AI predicting the next supply chain hiccup before we even see it coming—now that’s what I call a crystal ball upgrade! With advanced data analytics, we can forecast with pinpoint accuracy. It’s like having a GPS for our supply chain—just without the “recalculating” every time something goes off course.
Implementing green practices helps both the planet and our bottom line. Stronger relationships across the supply chain lead to smoother operations.
At JAS, our commitment to these strategies is reflected in our values and the dedication of our JAS family. By embracing innovation and working collaboratively, we can drive the industry forward and ensure that the pharmaceutical supply chain continues to meet the evolving needs of the global market.
Many thanks to Logipharma for an opportunity to connect with Industry leaders and work together on discussing these strategies! We hope to see you next year!
11. Are there any exciting projects that you’re currently working on or any past ones that you’re proud of that you’d like to highlight?
At JAS, we are constantly working on exciting projects to expand our capabilities in the Pharma & Healthcare sector, ensuring that we meet the growing demand for high-quality, temperature-controlled logistics. One of our most notable ongoing projects is the significant investment in our temperature-controlled facilities across the globe.
In Europe, we’re particularly excited about JAS Amsterdam, which will soon be ready to become a new home for pharmaceutical products. This facility is being developed with state-of-the-art temperature control systems that will allow us to handle sensitive Pharma products with precision and care, ensuring compliance with the strictest industry standards. It’s a key step in further strengthening our European network.
Additionally, we are upgrading our JAS CDG (Charles de Gaulle) facility to enhance its capabilities for handling Pharma shipments. These upgrades will improve our service offerings in the region, making it easier for us to manage the complexity of Pharma logistics and meet the needs of our customers with even greater efficiency.
And of course, we have exciting news coming soon from the United States, particularly in Miami. While I can’t reveal all the details just yet, it’s a project that we are incredibly proud of, as it will significantly boost our capacity to serve the Pharma & Healthcare sector in the Americas. This new development will further position JAS as a leader in temperature-controlled logistics, both in the US and globally.
12. How exciting a future does the pharmaceutical supply chain have?
The future of the pharmaceutical supply chain is nothing short of exhilarating! We are on the brink of a revolution where innovation, technology, and collaboration are set to transform the industry in ways we’re only beginning to imagine.
Imagine handling pallets not just with vaccines and medications but with 3D-printed hearts, limbs, and even an elixir of youth—now that is a supply chain I would love to manage! It is a future where our logistical challenges are matched only by the incredible advancements in medical technology.
Think about it: With advancements in AI, blockchain, and data analytics, we’re talking about supply chains that can anticipate issues before they even arise—like having a GPS that not only tells you where to go but also predicts traffic jams before you hit them!
The integration of these technologies means our supply chains will be faster, smarter, and more resilient. Imagine a world where disruptions are quickly addressed, inventory levels are optimised in real-time, and every shipment is tracked with absolute precision. It’s like having a crystal ball, but better—because it actually works!
Moreover, the push towards sustainability will not only help the environment but also make our operations more efficient. Less waste, smarter logistics, and greener practices will make us the superheroes of the supply chain world.
In short, the future of the pharmaceutical supply chain is bright, dynamic, and full of possibilities. With the continued evolution of technology and a focus on collaboration and sustainability, JAS is not just preparing for the future—we are creating it. So buckle up, because it’s going to be an exciting ride!
